equol and Osteoporosis
equol has been researched along with Osteoporosis in 12 studies
Research
Studies (12)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fujii, S; Fujioka, M; Ishimi, Y; Katsumata, S; Takeda, K; Uehara, M | 1 |
| Adlercreutz, H; Ishimi, Y; Katsumata, S; Masuyama, R; Ohtomo, T; Peñalvo, JL; Suzuki, K; Takeda, K; Uehara, M | 1 |
| Daub, F; Kolios, L; Rack, T; Sehmisch, S; Stuermer, EK; Stuermer, KM; Tezval, M | 1 |
| Jarry, H; Maehlmeyer, S; Sehmisch, S; Stuermer, EK; Stuermer, KM; Tezval, M; Uffenorde, J | 1 |
| Ishimi, Y | 1 |
| Legette, LL; Weaver, CM | 1 |
| Greiwe, JS; Jackson, RL; Schwen, RJ | 1 |
| Adlercreutz, H; Ishimi, Y; Katsumata, S; Kimira, Y; Suzuki, K; Uchiyama, S; Uehara, M; Ueno, T | 1 |
| Adlercreutz, H; Fujioka, M; Ishimi, Y; Kanazawa, K; Suzuki, K; Takeda, K; Uehara, M; Wu, J; Yamada, K | 1 |
| Bennetau-Pelissero, C; Coxam, V; Davicco, MJ; Fokialakis, N; Horcajada, MN; Kati-Coulibaly, S; Lamothe, V; Lebecque, P; Mardon, J; Mathey, J; Mitakou, S; Puel, C | 1 |
| Artur, Y; Bennetau-Pelissero, C; Bergès, R; Canivenc-Lavier, MC; Chevalier, J; Coxam, V; Davicco, MJ; Desmetz, C; Jover, E; Phrakonkham, P; Pinnert, MF | 1 |
| Rachoń, D; Seidlová-Wuttke, D; Vortherms, T; Wuttke, W | 1 |
Reviews
1 review(s) available for equol and Osteoporosis
| Article | Year |
|---|---|
Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.
Topics: Biomarkers; Biotransformation; C-Reactive Protein; Cardiovascular Diseases; Equol; Estrogen Receptor beta; Female; Humans; Intestines; Isoflavones; Lipoproteins, LDL; Male; Osteoporosis; Phytoestrogens; Prostatic Neoplasms; Risk Factors | 2011 |
Other Studies
11 other study(ies) available for equol and Osteoporosis
| Article | Year |
|---|---|
Kanamycin inhibits daidzein metabolism and abilities of the metabolites to prevent bone loss in ovariectomized mice.
Topics: Administration, Oral; Animals; Biotransformation; Body Weight; Bone Density; Diet; Disease Models, Animal; Equol; Female; Femur; Humans; Isoflavones; Kanamycin; Mice; Organ Size; Osteoporosis; Ovariectomy; Phytoestrogens; Uterus | 2016 |
Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures.
Topics: Animals; Bone Density; Coculture Techniques; Dose-Response Relationship, Drug; Equol; Estrogens, Non-Steroidal; Female; Isoflavones; Lipid Metabolism; Mice; Mice, Inbred Strains; Osteoclasts; Osteoporosis; Ovariectomy; Random Allocation | 2008 |
Equol but not genistein improves early metaphyseal fracture healing in osteoporotic rats.
Topics: Animals; Bony Callus; Disease Models, Animal; Elasticity; Equol; Estradiol; Estrogens; Female; Fracture Healing; Genistein; Glycine max; Isoflavones; Osteoclasts; Osteoporosis; Ovariectomy; Phytoestrogens; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Tibia | 2009 |
Evaluation of bone quality and quantity in osteoporotic mice--the effects of genistein and equol.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Agents; Equol; Estradiol; Female; Genistein; Isoflavones; Mice; Mice, Inbred C57BL; Osteoporosis; Ovariectomy; Phytoestrogens; Phytotherapy; Plant Extracts; Tibia | 2010 |
Dietary equol and bone metabolism in postmenopausal Japanese women and osteoporotic mice.
Topics: Animals; Bone and Bones; Bone Density; Diet; Double-Blind Method; Equol; Female; Humans; Isoflavones; Japan; Mice; Osteoporosis; Postmenopause; Randomized Controlled Trials as Topic | 2010 |
Equol, via dietary sources or intestinal production, may ameliorate estrogen deficiency-induced bone loss.
Topics: Animals; Bone Density; Bone Remodeling; Diet; Equol; Estrogens; Humans; Isoflavones; Osteoporosis | 2010 |
Comparative activities of the S-enantiomer and racemic forms of equol on bone fragility in ovariectomized mice.
Topics: Animals; Bone Density; Chromatography, High Pressure Liquid; Disease Models, Animal; Equol; Female; Femur; Humans; Mice; Osteoporosis; Osteoporotic Fractures; Ovariectomy; Phytoestrogens; Stereoisomerism | 2012 |
Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice.
Topics: Animals; Bone Density; Equol; Estrogens, Non-Steroidal; Female; Isoflavones; Mice; Osteoporosis; Ovariectomy; Structure-Activity Relationship | 2004 |
Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Topics: Animals; Biomarkers; Body Weight; Bone Density; Bone Resorption; Disease Models, Animal; Equol; Female; Femur; Genistein; Glycine max; Isoflavones; Organ Size; Osteocalcin; Osteoporosis; Ovariectomy; Phytoestrogens; Rats; Rats, Wistar; Uterus | 2007 |
Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats.
Topics: Animals; Bone Density; Cytochrome P-450 Enzyme System; Disease Models, Animal; Equol; Estradiol; Female; Gene Expression Regulation; Genistein; Isoflavones; Menopause; Microsomes, Liver; Organ Size; Osteoporosis; Ovariectomy; Phytoestrogens; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Uterus; Vagina | 2007 |
Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats.
Topics: Animals; Bone Density; Dietary Supplements; Equol; Estradiol; Female; Isoflavones; Osteoporosis; Ovariectomy; Phytoestrogens; Phytotherapy; Rats; Rats, Sprague-Dawley | 2007 |